Work with us
We test biomarkers that are currently not tested on any other platform.
MicroRNA genetics is a unique area that requires special expertise.
As our founders are leaders in the field of microRNA genetics, our platform of mutations are novel and not tested by others. With over 35 years of microRNA expertise behind us, we are able to narrow our focus on the most predictive and important germ-line mutations that impact microRNA function and signaling, leading to biomarker identification even in small patient numbers.
Interested in partnering with us?
Who does MiraDx partner with?
MiraDx has several academic partnerships, allowing sample access and panel development. Some examples are the Radiogenomics program with UCLA, as well as with OSLO University. Together with these institutions, MiraDx is personalizing radiation in ways never before thought to be possible.
MiraDx also has industry partnerships, where clinical trial samples are studied collaboratively at MiraDx and biomarkers applied, analysis done to define biomarker panels, and panels developed for commercial distribution.